Abhinav Sidana, MD, MPH, presented “Combination of Prostate Ablation with Systemic Therapy for Management of Prostate” during the 7th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2023.
This content is available free to the GRU Community. Login or create an account to view it.
How to cite: Sidana, Abhinav. “Combination of Prostate Ablation with Systemic Therapy for Management of Prostate.” September 23, 2023. Accessed Nov 2024. https://grandroundsinurology.com/combination-of-prostate-ablation-with-systemic-therapy-for-management-of-prostate/
Combination of Prostate Ablation with Systemic Therapy for Management of Prostate – Summary
Abhinav Sidana, MD, MPH, addresses the integration of prostate ablation with systemic therapy for the management of prostate cancer. This strategy aims at improving treatment outcomes through synergistic effects and personalized care.
Prostate ablation techniques, including cryoablation or high-intensity focused ultrasound (HIFU), target localized prostate tumors while preserving surrounding healthy tissue. Dr. Sidana emphasizes that these minimally invasive procedures offer potential advantages over traditional treatments by reducing treatment-related side effects such as urinary incontinence and erectile dysfunction. The integration of systemic therapy, such as hormonal therapy or chemotherapy, complements prostate ablation by addressing systemic disease and enhancing treatment efficacy.
By leveraging both local and systemic treatment modalities, clinicians can tailor treatment strategies to individual patient profiles, ultimately improving long-term survival and quality of life for prostate cancer patients.
The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a unique multi-disciplinary forum organized to inform the key health care stakeholders about the emerging advances in clinical case and research and create a consensus-based vision for the future of precision care and educational and research strategy for its realization. The mission of the Summit is to fill the currently existing gap between the key experts of in vivo imaging, the world authorities in the in vitro fluid- and tissue-based molecular diagnostics, including genomics, and thought leaders in the development of novel observation strategies (e.g., active surveillance, or AS) and therapeutic interventions.
ABOUT THE AUTHOR
Abhinav Sidana, MD, MPH, is the Director of Prostate Cancer Focal Therapy, Director of GU Clinical Trials Urology Section, and Associate Professor of Surgery at the University of Chicago Medicine and Biological Sciences in Chicago, IL. Dr. Sidana earned his MD in 2007 from the All India Institute of Medical Sciences in New Delhi. Following this, he pursued a post-doctoral Fellowship in Urology at Johns Hopkins University School of Medicine in Baltimore, Maryland, during which he focused on translational projects relating to cancer immunotherapy and was instrumental in translating the preclinical work for a clinical trial studying cryo-immunotherapy. Subsequently, he completed his urology residency at the University of Cincinnati Medical Center and a urologic oncology fellowship at the National Cancer Institute of the National Institutes of Health. Dr. Sidana’s current clinical practice includes both surgical and non-operative management of prostate, kidney, ureteral, testicular, and bladder cancers. His research interests include functional prostate imaging, image-guided and focal treatments for prostate cancer, and clinical trials on novel treatments for urologic cancers.
